Hedge Fund - Resolute Capital Asset Partners
Ascendis Pharma A/S (ASND)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $26,106,550 | 14.69% | 167,500 | $142.85 |
| 2 | 2024 - Q4 (2024-12-31) | $15,763,000 | 8.47% | 114,500 | $131.48 |
| 3 | 2024 - Q3 (2024-09-30) | $15,603,000 | 8.11% | 104,500 | $135.05 |
| 4 | 2024 - Q2 (2024-06-30) | $6,410,000 | 3.68% | 47,000 | $136.06 |
| 5 | 2024 - Q1 (2024-03-31) | $7,105,000 | 3.71% | 47,000 | $142.72 |
| 6 | 2023 - Q4 (2023-12-31) | $4,585,000 | 2.98% | 36,400 | $99.70 |
| 7 | 2023 - Q3 (2023-09-30) | $3,512,000 | 2.47% | 37,500 | $93.55 |
| 8 | 2023 - Q2 (2023-06-30) | $3,347,000 | 2.37% | 37,500 | $87.09 |
| 9 | 2023 - Q1 (2023-03-31) | $4,021,000 | 2.93% | 37,500 | $114.40 |
| 10 | 2022 - Q4 (2022-12-31) | $4,580,000 | 4.08% | 37,500 | $116.10 |
| 11 | 2022 - Q3 (2022-09-30) | $3,098,000 | 2.77% | 30,000 | $94.81 |
| 12 | 2022 - Q2 (2022-06-30) | $1,859,000 | 1.33% | 20,000 | $94.25 |
| 13 | 2022 - Q1 (2022-03-31) | $2,347,000 | 1.49% | 20,000 | $115.81 |
The displayed share prices are average quarterly stock market prices.